EMILY PILOTE: Open Payments
NPI 1447491667 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,141 in 95 payments from 20 companies in 2025. Trend: 2023 $1,151 · 2024 $1,740 · 2025 $2,141
Food & beverage: $2,114Consulting: $26
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $544 |
| GENZYME CORPORATION | 9 | $255 |
| Amgen Inc. | 11 | $186 |
| GlaxoSmithKline, LLC. | 10 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $121 |
| Regeneron Healthcare Solutions, Inc. | 5 | $118 |
| Optinose US, Inc. | 4 | $99 |
| CSL Behring | 4 | $87 |
| PFIZER INC. | 3 | $83 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
Products named: TEZSPIRE, DUPIXENT, FASENRA, AIRSUPRA, CUVITRU, NUCALA, Xhance, Xolair.
Industry payments across TN — which companies pay providers there.
